ムービー
コントローラー
構造ビューア
EMN検索について
-検索条件
-検索結果
検索 (著者・登録者: hashiguchi & t)の結果81件中、1から50件目までを表示しています
EMDB-37910: 
Structure of the SARS-CoV-2 BA.2.86 spike glycoprotein (closed state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-38686:
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-38687:
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-38688:
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-38689:
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-60886:
Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-8wxl:
Structure of the SARS-CoV-2 BA.2.86 spike glycoprotein (closed state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-8xux:
Structure of the SARS-CoV-2 BA.2.86 spike protein (1-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-8xuy:
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-8xuz:
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-8xv0:
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-8xv1:
Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-8xvm:
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
PDB-9iu1:
Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-38459:
Structure of the SARS-CoV-2 BA.2.86 spike protein (1-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-38690:
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-60904:
Structure of SARS-CoV-2 JN.1 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-60905:
Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (1 highly-open RBD and 1 partially-open RBD)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-60906:
Structure of SARS-CoV-2 JN.1 spike glycoprotein in complex with ACE2 (2-up and 1-down state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Maenaka K, Hashiguchi T
EMDB-38453:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state)
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
EMDB-38454:
Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
PDB-8xlm:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state)
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
PDB-8xln:
Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
EMDB-37648:
SARS-CoV-2 EG.5.1 spike glycoprotein (1-up state)
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
EMDB-37650:
SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state)
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
EMDB-37651:
SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state)
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
PDB-8wmd:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state)
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
PDB-8wmf:
Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state)
手法: 単粒子 / : Nomai T, Anraku Y, Kita S, Hashiguchi T, Maenaka K
EMDB-36724:
Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 1)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36726:
Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 2)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36727:
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36728:
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36729:
Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8jyk:
Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 1)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8jym:
Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 2)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8jyn:
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8jyo:
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state)
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
PDB-8jyp:
Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2
手法: 単粒子 / : Yajima H, Anraku Y, Kita S, Kimura K, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-36905:
SARS-CoV-2 BA.1 RBD with UT28-RD
手法: 単粒子 / : Chen L, Kita S, Anraku Y, Maenaka K
EMDB-36906:
SARS-CoV-2 BA.1 spike with UT28-RD
手法: 単粒子 / : Chen L, Kita S, Anraku Y, Maenaka K
PDB-8k5g:
Structure of the SARS-CoV-2 BA.1 RBD with UT28-RD
手法: 単粒子 / : Chen L, Kita S, Anraku Y, Maenaka K
PDB-8k5h:
Structure of the SARS-CoV-2 BA.1 spike with UT28-RD
手法: 単粒子 / : Chen L, Kita S, Anraku Y, Maenaka K
EMDB-34741:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-34742:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
PDB-8hgl:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
PDB-8hgm:
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33820:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33821:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33822:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33823:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
手法: 単粒子 / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
ページ:
wwPDBはEMDBデータモデルのバージョン3へ移行します
